Richard C. Chao
- Oncology top 0.5%
- Epidemiology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Neurology top 1%
- Co-authors
- Juan W. ValleJean‐Luc RaoulShem PatynaYung‐Jue BangÉric RaymondIvan BorbathPeter MetrakosCatherine Lombard‐Bohas
- Topics
- Lung Cancer Treatments and Mutations (48 papers)Colorectal Cancer Treatments and Studies (29 papers)Pancreatic and Hepatic Oncology Research (23 papers)
- Cited by
- OncologyNeurologyEpidemiology
- Partner nations
- United StatesItalyCanada
In The Last Decade
Richard C. Chao
87 papers receiving 4.1k citations
Hit Papers
Peers
Comparison fields: 5 of 92
- Oncology 2.9k
- Epidemiology 1.7k
- Pulmonary and Respiratory Medicine 1.4k
- Molecular Biology 1.3k
- Neurology 1.2k
Countries citing papers authored by Richard C. Chao
This map shows the geographic impact of Richard C. Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard C. Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard C. Chao more than expected).
Fields of papers citing papers by Richard C. Chao
This network shows the impact of papers produced by Richard C. Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard C. Chao. The network helps show where Richard C. Chao may publish in the future.
Co-authorship network of co-authors of Richard C. Chao
This figure shows the co-authorship network connecting the top 25 collaborators of Richard C. Chao. A scholar is included among the top collaborators of Richard C. Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard C. Chao. Richard C. Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 37 | |
| 3 | 13 | |
| 4 | 4 | |
| 5 | 3 | |
| 6 | 47 | |
| 7 | Progression-Free Survival (PFS) by Blinded Independent Central Review (BICR) and Updated Overall Survival (OS) of Sunitinib versus Placebo for Patients with Progressive, Unresectable, Well Differentiated Pancreatic Neuroendocrine Tumor (NET) | 4 |
| 8 | 22 | |
| 9 | 34 | |
| 10 | 24 | |
| 11 | Evaluation of Progression-Free Survival by Blinded Independent Central Review in Patients With Progressive, Well-Differentiated Pancreatic Neuroendocrine Tumors Treated With Sunitinib or Placebo | 2 |
| 12 | Overall Survival (OS) Analysis of Sunitinib (SU) after Adjustment for Crossover (CO) in Patients with Pancreatic Neuroendocrine Tumors (NET) | 1 |
| 13 | 41 | |
| 14 | 11 | |
| 15 | Biomarker Associations With Survival for Refractory NSCLC Patients Receiving Erlotinib +/- Sunitinib in a Randomized Phase 2 Trial | 1 |
| 16 | 38 | |
| 17 | 1 | |
| 18 | 5 | |
| 19 | 33 | |
| 20 | 39 |
About Richard C. Chao
Richard C. Chao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Gastroenterology, having authored 90 papers that have together received 4.1k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (48 papers), Colorectal Cancer Treatments and Studies (29 papers) and Pancreatic and Hepatic Oncology Research (23 papers). The work is most often cited by research in Oncology (2.9k citations), Neurology (1.2k citations) and Epidemiology (1.7k citations). Richard C. Chao has collaborated with scholars based in United States, Italy and Canada. Frequent co-authors include Juan W. Valle, Jean‐Luc Raoul, Shem Patyna, Yung‐Jue Bang, Éric Raymond, Ivan Borbath, Peter Metrakos, Catherine Lombard‐Bohas, Dieter Hörsch and Aaron I. Vinik. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.